The Special Investment Facilitation Council's support has resulted in a positive economic impact due to the implementation of deregulation policy in the pharmaceutical industry.

After the implementation of the deregulation policy, the profit of the pharmaceutical sector surged by 13.5 billion rupees and witnessed a 210 percent increase.

Meanwhile, the profit of three important companies in the pharma sector has also increased by 44 percent to 339 percent.

The pharmaceutical industry has become more attractive to investors, and annual exports are likely to reach five billion dollars as global investment prospects are brightened with the deregulation policy.

The deregulation policy is making possible to increase transparency in drug prices, increase competition, and access to quality drugs.

Under the policy, companies are encouraged to increase innovative research on new drugs, and further improvement in the production of quality drugs is expected.

Additionally, prevention of substandard and expensive drugs are also being ensured.

The country's pharma industry is moving on the path of development with the support of SIFC, which is a guarantee of economic stability.